A 45-year-old woman is admitted with meningitis. CSF analysis shows: protein 180 mg/dL, glucose 25 mg/dL (serum glucose 110 mg/dL), WBC 850/μL (90% neutrophils), and Gram stain shows gram-positive diplococci. Blood cultures are pending. What is the most appropriate immediate management?

Question

Accepted Answer

B. Start vancomycin 15–20 mg/kg IV 8–12-hourly plus ceftriaxone 2 g IV 12-hourly plus rifampin. ## Clinical Diagnosis
This patient has bacterial meningitis with CSF findings classic for *Streptococcus pneumoniae*:
- Low CSF glucose (25 mg/dL; CSF:serum ratio = 0.23, well below the normal ≥0.6)
- Elevated protein (180 mg/dL)
- Neutrophil-predominant pleocytosis (850 WBC/μL, 90% PMNs)
- Gram-positive diplococci on Gram stain

## Rationale for Correct Answer (B)

**Key Point:** Current IDSA guidelines (Tunkel et al.) and Harrison's Principles of Internal Medicine (21e, Ch. 297) recommend **empiric vancomycin + ceftriaxone** for suspected pneumococcal meningitis, with **rifampin added** when highly penicillin-resistant or cephalosporin-resistant strains are suspected or confirmed.

The rationale for triple therapy:
1. **Vancomycin** covers penicillin- and cephalosporin-resistant *S. pneumoniae* (PRSP), which now account for a significant proportion of isolates globally.
2. **Ceftriaxone** provides broad coverage of penicillin-susceptible and intermediate strains and achieves adequate CSF bactericidal levels.
3. **Rifampin** has excellent CSF penetration and is added as an adjunct when cephalosporin-resistant pneumococci are a concern; it acts synergistically with vancomycin and ceftriaxone.

**Why not the other options?**
- **Option A (Penicillin G alone):** Penicillin resistance in *S. pneumoniae* is well-established worldwide; monotherapy risks treatment failure and is no longer recommended empirically.
- **Option C (Repeat LP):** Lumbar puncture has already been performed and yielded diagnostic CSF. Delaying antibiotics to repeat LP is dangerous and not indicated.
- **Option D (Ceftriaxone alone):** Monotherapy with ceftriaxone is insufficient when penicillin/cephalosporin-resistant strains cannot be excluded; vancomycin must be added empirically until susceptibilities are known.

**Clinical Pearl:** Dexamethasone 0.15 mg/kg IV every 6 hours for 4 days should be administered **before or with the first antibiotic dose** to reduce meningeal inflammation, decrease cytokine-mediated injury, and lower the risk of neurological sequelae (Harrison 21e). It also transiently reduces CSF vancomycin penetration, which is one reason rifampin is added in resistant cases.

## Dosing in Meningitis
| Drug | Dose | Frequency | CSF Penetration |
|------|------|-----------|-----------------|
| Vancomycin | 15–20 mg/kg | IV q8–12h | ~10–20% (inflamed meninges) |
| Ceftriaxone | 2 g | IV q12h | ~10–20% (inflamed meninges) |
| Rifampin | 600 mg | IV/PO q12h | Excellent (>50%) |
| Dexamethasone | 0.15 mg/kg | IV q6h × 4 days | — |

**High-Yield Mnemonic:** **VCR** = **V**ancomycin + **C**eftriaxone + **R**ifampin for empiric pneumococcal meningitis when resistance is a concern.

*References: Harrison's Principles of Internal Medicine, 21e, Ch. 297; IDSA Practice Guidelines for Bacterial Meningitis (Tunkel et al., CID 2004, updated 2017).*

Answer

A. Start penicillin G 4 million units IV 4-hourly and observe clinical response

Answer

C. Perform lumbar puncture again to obtain adequate CSF for culture

Answer

D. Start ceftriaxone 2 g IV 12-hourly alone and await culture confirmation

A 45-year-old woman is admitted with meningitis. CSF analysis shows: protein 180 mg/dL, glucose 25 mg/dL (serum glucose 110 mg/dL), WBC 850/μL (90% neutrophils), and Gram stain shows gram-positive diplococci. Blood cultures are pending. What is the most appropriate immediate management?

Explanation

Practice similar questions